Medicare-X Choice Act of 2025

Bill Number

S. 3369

Origin Chamber

Senate

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-12-04: Read twice and referred to the Committee on Finance.

Last Updated

2026-01-07T16:33:08Z

AI-Generated Summary

Purpose of the Legislation

The Medicare-X Choice Act of 2025 aims to create a new public health insurance option, called the Medicare Exchange health plan (or "Medicare-X"), to offer affordable, high-quality coverage through the Affordable Care Act (ACA) marketplaces. This plan is designed to increase competition in the individual and small group insurance markets, lower premiums, and improve access to care while building on existing federal health programs like Medicare.

Key Provisions

• Establishment and Funding: Adds a new Title XXII to the Social Security Act to create the Medicare-X plan, administered by the Secretary of Health and Human Services (HHS). Establishes two funds in the U.S. Treasury: a $1 billion Plan Reserve Fund for setup and operations (fiscal years 2027–2036) and a $1 billion Data and Technology Fund for data collection and premium setting. HHS must issue final rules within 270 days of enactment.

• Availability and Eligibility: The plan becomes available nationwide in all rating areas (geographic zones for pricing) starting in plan year 2028 for both individual and small group markets via ACA Health Insurance Exchanges (including the Small Business Health Options Program). Eligible individuals are those who qualify for ACA subsidies but are not enrolled in traditional Medicare (for seniors and certain disabled people).

• Plan Design and Benefits: Functions as a "qualified health plan" under ACA rules, offering silver and gold coverage levels (mid- and high-tier plans with defined benefits). May offer up to two versions per coverage level (bronze, silver, gold, platinum). Covers primary care services with no out-of-pocket costs to enrollees. Allows for future study and recommendations on adding benefits like dental, vision, hearing, long-term care, and home-based services.

• Premiums and Risk Pooling: Premiums are set to cover full costs (benefits plus administration) and vary by location and market type. For 2028, based on 2027 private plan rates. After 2028, uses a single statewide risk pool for enrollees (or separate individual/small group pools in some states) to spread costs evenly.

• Provider Payments and Participation: Pays providers at Medicare fee-for-service rates (standard government rates for doctor visits, hospital stays, etc.), with up to 50% increases in rural areas. Negotiates prices for prescription drugs (potentially linking to Medicare processes). Requires most Medicare and Medicaid providers to participate starting in 2028, with an opt-out process for exceptional cases (e.g., financial hardship). Bars providers who discriminate against Medicare-X patients from federal health programs.

• Delivery System Reforms: Encourages innovative payments like accountable care organizations (groups of providers sharing responsibility for patient care costs), value-based care (payments tied to outcomes, not volume), telehealth, and bundling services. Integrates with social services (e.g., food, housing aid) via grants for community partnerships. Promotes reducing health disparities (differences in care access based on race, income, location, disability, etc.).

• Reinsurance and Tax Credits: Creates a nationwide reinsurance program to pool costs for the highest-expense patients ($10 billion authorized for 2028–2030) to lower overall premiums. Expands ACA premium tax credits: removes the 400% federal poverty level income cap, adjusts subsidy percentages (e.g., 0% for incomes up to 150% poverty, up to 8.5% for higher incomes), limits repayment of excess subsidies to $5,000 for high earners, and fixes the "family glitch" (where family coverage affordability was miscalculated based on individual rates).

• Drug Pricing and Antitrust: Removes the ban on Medicare negotiating prices for all prescription drugs (previously limited to certain high-cost drugs). Allocates $50 million to the Department of Justice Antitrust Division and $100 million to the Federal Trade Commission (FTC) annually (2027–2031) for studying health care market competition and enforcing antitrust laws against anti-competitive practices (e.g., mergers that raise prices).

• Reporting and Oversight: Requires HHS to study expanding benefits and submit a report to Congress within two years. DOJ and FTC must report to Congress on antitrust activities within one year and a comprehensive review by 2032.

• Protections: Explicitly states no impact on existing Medicare benefits or trust funds. Contracts for administration do not transfer financial risk to private entities (except in specific alternative payment models).

Significant Changes to Existing Law

• ACA Integration: Introduces a government-run plan as a qualified health plan on ACA exchanges, competing directly with private insurers—unlike current law, which lacks such a public option.
• Provider Mandates: Newly requires Medicare and Medicaid providers to accept Medicare-X patients (with opt-outs), and excludes discriminatory providers from federal programs—expanding beyond voluntary participation.
• Tax Credits: Eliminates the 400% income limit for ACA subsidies (previously cutting off aid above that level), revises subsidy tiers for broader affordability, and corrects the family coverage affordability test under the Internal Revenue Code.
• Drug Negotiation: Strikes the prohibition on Medicare negotiating all drug prices under the Social Security Act, allowing broader price controls.
• Reinsurance: Adds a permanent nationwide high-cost patient pool outside the temporary ACA reinsurance (which ended in 2016).
• Antitrust Funding: Provides new dedicated appropriations for health care market enforcement, amending the Social Security Act.

Potential Impacts

• On Citizens: Could lower insurance premiums through competition, reinsurance, and expanded subsidies, making coverage more accessible for individuals and small businesses (especially those above 400% poverty). Improves primary care access with zero cost-sharing and promotes equity by addressing disparities. May increase choices but could shift some from employer plans if more affordable.

• On Government Agencies: HHS and Centers for Medicare & Medicaid Services (CMS) gain major administrative responsibilities, including plan operation, data collection, and reforms—potentially straining resources despite initial funding. DOJ and FTC receive boosts for enforcement, possibly leading to more investigations. Federal costs rise from appropriations ($12 billion initially, plus reinsurance and grants), offset by premium collections and negotiations.

• On International Relations: No direct impacts; focuses on domestic health policy.

Main Stakeholders Affected

• Individuals and Families: Primary beneficiaries, gaining a low-cost public option and enhanced subsidies, particularly middle- and higher-income households previously ineligible for aid.
• Small Businesses and Employers: Access to the plan in group markets; "family glitch" fix may reduce reliance on employer coverage.
• Health Care Providers: Medicare/Medicaid doctors and hospitals must participate, facing Medicare rates (potentially lower than private insurance) but with rural boosts and innovation incentives.
• Insurers and Private Plans: Increased competition from a public option, plus reinsurance benefits, could pressure pricing but stabilize markets.
• Pharmaceutical Companies: Subject to government drug price negotiations, potentially reducing profits on Medicare-related sales.
• Government Entities: HHS/CMS (administration), IRS (tax credits), DOJ/FTC (antitrust), and states (via exchanges and Medicaid ties).
• Vulnerable Groups: People with disabilities, older adults, rural residents, and underserved communities benefit from disparity reductions, telehealth, and potential benefit expansions.

Notable Legal, Constitutional, or Political Implications

• Legal: Amends core laws like the Social Security Act, Public Health Service Act, and Internal Revenue Code to integrate the public plan seamlessly with ACA frameworks. Introduces enforceable provider non-discrimination rules and opt-out processes, which could lead to litigation over participation mandates. Privacy protections (e.g., HIPAA) apply to data collection.

• Constitutional: Builds on ACA's foundation (upheld under the Commerce Clause for regulating insurance markets), but the public option and provider requirements may raise federalism concerns if seen as coercing states or providers—though opt-outs mitigate this. No direct challenges to free speech or due process noted.

• Political: Revives public option debates from ACA negotiations, positioning it as a moderate expansion of government involvement without full single-payer. Emphasizes cost control (e.g., drug negotiations, antitrust) to appeal across parties, but funding and mandates could spark partisan divides over federal spending and market interference. Requires congressional reports for ongoing oversight.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Bennet, Michael F. [D-CO]

Cosponsors (10)

Sen. Kaine, Tim [D-VA], Sen. Booker, Cory A. [D-NJ], Sen. Duckworth, Tammy [D-IL], Sen. Smith, Tina [D-MN], Sen. Warnock, Raphael G. [D-GA], Sen. Hickenlooper, John W. [D-CO], Sen. Klobuchar, Amy [D-MN], Sen. Peters, Gary C. [D-MI], Sen. Slotkin, Elissa [D-MI], Sen. Shaheen, Jeanne [D-NH]

Recent Actions

• 2025-12-04: Read twice and referred to the Committee on Finance.
• 2025-12-04: Introduced in Senate

Bill Versions

• Medicare-X Choice Act of 2025 — issued 2025-12-04 — PDF (24 pages)